Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3085195
Max Phase: Preclinical
Molecular Formula: C53H70F2N2O16
Molecular Weight: 1029.14
Molecule Type: Unknown
Associated Items:
ID: ALA3085195
Max Phase: Preclinical
Molecular Formula: C53H70F2N2O16
Molecular Weight: 1029.14
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@@]2(OC1)OC1CC3C4CC[C@H]5C[C@@H](O[C@@H]6O[C@@H](CO)[C@@H](O[C@@H]7O[C@@H](COC(=O)Nc8ccccc8F)[C@@H](OC(=O)Nc8ccccc8F)[C@H](O)[C@@H]7O)[C@H](O)[C@@H]6O)CC[C@]5(C)C4C(=O)C[C@]3(C)C1[C@@H]2C
Standard InChI: InChI=1S/C53H70F2N2O16/c1-25-15-18-53(67-23-25)26(2)39-36(73-53)20-30-29-14-13-27-19-28(16-17-51(27,3)40(29)35(59)21-52(30,39)4)68-47-43(62)41(60)45(37(22-58)69-47)71-48-44(63)42(61)46(72-50(65)57-34-12-8-6-10-32(34)55)38(70-48)24-66-49(64)56-33-11-7-5-9-31(33)54/h5-12,25-30,36-48,58,60-63H,13-24H2,1-4H3,(H,56,64)(H,57,65)/t25-,26+,27+,28+,29?,30?,36?,37+,38+,39?,40?,41-,42-,43+,44+,45-,46-,47-,48+,51+,52+,53-/m1/s1
Standard InChI Key: SGDORIGXKDQJMG-AHXAWENZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1029.14 | Molecular Weight (Monoisotopic): 1028.4693 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. DeNinno MP, McCarthy PA, Duplantier KC, Eller C, Etienne JB, Zawistoski MP, Bangerter FW, Chandler CE, Morehouse LA, Sugarman ED, Wilkins RW, Woody HA, Zaccaro LM.. (1997) Steroidal glycoside cholesterol absorption inhibitors., 40 (16): [PMID:9258361] [10.1021/jm9702600] |
Source(1):